Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 29, 2025 09:00 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon

Orchestra BioMed’s Virtue® Sirolimus AngioInfusion Balloon™ (“Virtue SAB”) is the only non-coated drug-eluting balloon system under clinical investigation worldwide and has been awarded multiple FDA...
April 29, 2025 08:00 ET | Source: Franklin Electric Co., Inc.

Franklin Electric Reports First Quarter 2025 Results

First Quarter 2025 Highlights Consolidated net sales of $455.2 million, a decrease of 1% to the prior yearEnergy Systems net sales increased 8% while Water Systems net sales were up less than 1% and...
April 29, 2025 08:00 ET | Source: ACM Research, Inc.

ACM Research Announces Preliminary Unaudited Revenue and Shipments for the First Quarter 2025

Coincides with Release of ACM Shanghai First Quarter 2025 ResultsACM Reaffirms 2025 Revenue Outlook FREMONT, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a...
April 29, 2025 08:00 ET | Source: Cingulate Inc.

Cingulate Announces Positive Top-Line Results from High-Dose (50mg) Fed/Fast Study of Lead Asset CTx-1301 for ADHD

Primary Endpoints Demonstrate CTx-1301 Can be Taken With or Without Food CTx-1301 is Designed as a True, Entire Active-Day Treatment for ADHD KANSAS CITY, Kan., April 29, 2025 (GLOBE NEWSWIRE) --...
April 29, 2025 08:00 ET | Source: Solid Biosciences Inc.

Solid Biosciences to Present at the American Society of Gene and Cell Therapy’s 28th Annual Meeting

CHARLESTOWN, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases,...
April 29, 2025 07:30 ET | Source: Repligen Corporation

Repligen Reports First Quarter 2025 Financial Results

Revenue of $169 million, year-over-year increase of 10% as reported and 14% organic non-COVID growthOrders increased sequentially and high-teens year-over-year Adjusted operating income increased 72%...
April 29, 2025 07:15 ET | Source: MiniLuxe Holding Corp.

MINILUXE REPORTS FULL-YEAR FINANCIAL RESULTS FOR YEAR ENDED DECEMBER 29, 2024

All reported figures in U.S. Dollars unless otherwise noted Boston, MA, April 29, 2025 (GLOBE NEWSWIRE) -- MiniLuxe Holding Corp. (TSXV: MNLX) today announced its financial results for the 52...
April 29, 2025 07:00 ET | Source: Seres Therapeutics, Inc.

Seres Therapeutics Presents Data at the 2025 Digestive Disease Week Conference Highlighting the Potential for Live Biotherapeutics to Treat Inflammatory and Immune Diseases

CAMBRIDGE, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that it will present three related posters at...
April 29, 2025 07:00 ET | Source: Amplify ETFs

Amplify ETFs Launches the Next Generation of Bitcoin Option Income ETFs

Amplify ETFs announces the launch of the Amplify Bitcoin 24% Premium Income ETF (BITY) and Amplify Bitcoin Max Income Covered Call ETF (BAGY).
April 29, 2025 07:00 ET | Source: EDAP TMS S.A.

EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting

Final 3-year outcome of Focal Ablation versus Radical Prostatectomy (FARP) Randomized Controlled Trial (RCT) presented at 120th AUA Annual Meeting on Sunday, April 27, 2025. Study achieved its primary...